Every peptide and biotech company needs regulatory expertise to bring products to market. The big question is whether to hire a full-time regulatory affairs professional or bring in a consultant.
This decision can shape your company's speed to market, budget, and overall regulatory strategy. Getting it wrong means wasted money or, worse, costly delays in your product pipeline.
- Most early-stage peptide companies benefit from starting with a regulatory consultant before committing to a full-time hire.
- Full-time regulatory hires become cost-effective when your company maintains three or more active submissions annually.
- A hybrid approach combining a core employee with specialized consultants offers flexibility as regulatory needs evolve.
- Always verify that consultants have direct peptide therapeutics experience, not just general biotech regulatory backgrounds.
- Protect intellectual property by establishing clear confidentiality agreements before sharing proprietary data with any consultant.
- Budget the true cost of a full-time hire at 1.3 to 1.5 times base salary when factoring in benefits and overhead.
The Regulatory Landscape for Peptide Companies
Peptide therapeutics face a complex regulatory path that spans synthesis, purification, formulation, and clinical development. The FDA, EMA, and other global agencies each have their own requirements and expectations.
Navigating this landscape requires deep knowledge of chemistry, manufacturing, and controls (CMC) documentation, IND submissions, and post-market compliance. Not every company needs this expertise full-time, but every company needs it at some point.
According to the Tufts Center for the Study of Drug Development, the average cost of developing a new drug through FDA approval exceeds $2.6 billion. Regulatory missteps are one of the leading causes of delays and cost overruns, making expert guidance critical for peptide companies of all sizes.
As Peter Tollman, Senior Partner at Boston Consulting Group, noted in BCG's 2024 Global Biopharma Perspective: "The most successful biotech companies don't choose between consultants and full-time hires. They sequence them, using consultants to establish regulatory strategy early, then building internal teams as their pipelines mature."
Understanding Your Two Options
Before diving into the comparison, let us define what each option looks like in practice. The terms "consultant" and "full-time hire" cover a wide range of arrangements.
A regulatory consultant is an independent expert or a professional from a consulting firm who works with your company on a project or retainer basis. A full-time hire is a salaried employee who works exclusively for your organization.
What a Regulatory Consultant Does
Consultants typically handle specific deliverables like IND preparation, regulatory strategy development, or agency meeting support. They bring experience from working across multiple companies and therapeutic areas.
Most consultants bill by the hour or by the project. Some offer retainer arrangements where they provide a set number of hours per month.
What a Full-Time Regulatory Hire Does
A full-time employee manages your ongoing regulatory operations day to day. They handle submissions, maintain compliance records, interact with agencies, and build your internal regulatory systems.
They become deeply embedded in your company's culture, products, and long-term strategy. Over time, they develop institutional knowledge that is hard to replace.
The average time to fill a senior regulatory affairs position in biotech exceeds 120 days, according to BioSpace workforce data, which means relying solely on a full-time hiring strategy can leave critical submissions without expert oversight for months.
Side-by-Side Comparison
Here is a detailed comparison of the two options across the factors that matter most.
| Factor | Regulatory Consultant | Full-Time Hire |
|---|---|---|
| Annual cost | $100,000 to $250,000 (project-dependent) | $120,000 to $200,000 (salary plus benefits) |
| Availability | Scheduled or on-demand | Always available during work hours |
| Ramp-up time | Fast, brings ready-made expertise | 3 to 6 months to learn your products |
| Breadth of experience | Wide, across many companies | Deep, within your company |
| Company loyalty | Limited, serves multiple clients | High, invested in your success |
| Scalability | Easy to scale up or down | Hard to scale, requires new hires |
| Institutional knowledge | Low, does not live in your company | High, builds over time |
| Regulatory network | Broad, from multiple engagements | May be narrower |
| Long-term cost for ongoing needs | Higher over time | Lower over time |
| Flexibility | High | Low |
Cost Analysis: Consultant vs Full-Time
Let us break down the real numbers. Many companies only compare salary to hourly rate, but the full picture is more complex.
A senior regulatory affairs professional in biotech earns between $130,000 and $180,000 in base salary. Add benefits, taxes, office space, and equipment, and the total cost reaches $170,000 to $250,000 per year.
Consultant Cost Breakdown
Regulatory consultants in the peptide and biotech space typically charge $150 to $350 per hour. Project-based fees for specific deliverables can also vary widely.
| Deliverable | Typical Consultant Cost | Typical Timeline |
|---|---|---|
| Regulatory strategy assessment | $15,000 to $30,000 | 4 to 6 weeks |
| Pre-IND meeting package | $30,000 to $60,000 | 6 to 10 weeks |
| IND submission preparation | $75,000 to $150,000 | 3 to 6 months |
| NDA/BLA support | $150,000 to $300,000+ | 6 to 12 months |
| Annual regulatory maintenance | $50,000 to $100,000 | Ongoing |
| Agency meeting preparation | $10,000 to $25,000 per meeting | 2 to 4 weeks |
Full-Time Hire Cost Breakdown
A full-time hire covers all of these activities under one salary. But you also pay for their time during slower periods when regulatory workload dips.
| Cost Component | Annual Cost Range |
|---|---|
| Base salary | $130,000 to $180,000 |
| Benefits (health, dental, vision) | $15,000 to $25,000 |
| Retirement contributions | $6,500 to $13,500 |
| Payroll taxes | $10,000 to $14,000 |
| Office space and equipment | $5,000 to $15,000 |
| Training and conferences | $3,000 to $8,000 |
| Total | $169,500 to $255,500 |
"For early-stage peptide companies with one or two products in the pipeline, a consultant almost always makes more financial sense," says Dr. Rebecca Torres, a regulatory affairs veteran with 20 years of biotech experience. "But once you have three or more active regulatory projects, the math shifts heavily toward a full-time hire."
When a Consultant Is the Right Choice
There are clear situations where hiring a consultant is the smarter move. Knowing when to use this option can save you significant money and get you better results.
Choose a consultant when your regulatory needs are project-based or seasonal. If you only need help preparing an IND or navigating a specific submission, a consultant delivers focused expertise without a long-term commitment.
Best Scenarios for Consultants
Early-stage companies with limited funding benefit most from consultants. You get senior-level expertise without the overhead of a full-time salary and benefits package.
Companies entering a new regulatory market, like expanding from the US to the EU, also benefit from consultants who already know the local requirements. This is faster and cheaper than training an existing employee on a new regulatory framework.
Consultants are also ideal when you need a second opinion on your regulatory strategy. An outside perspective can catch blind spots that internal teams miss.
Before hiring a regulatory consultant, ask for references from peptide or peptide-adjacent programs they have supported through IND filing, not just general biologics work. CMC requirements for synthetic peptides differ significantly from those for large-molecule biologics, and that distinction matters at every stage of your submission.
When a Full-Time Hire Is the Right Choice
A dedicated employee makes more sense when your regulatory workload is consistent and ongoing. If you have regulatory tasks happening every week, a full-time person is more efficient.
Companies with multiple products in different stages of development almost always need at least one full-time regulatory professional. The coordination across programs requires someone who is deeply embedded in your organization.
Best Scenarios for Full-Time Hires
If you are managing post-market compliance for approved products, you need someone on staff to handle the day-to-day requirements. Annual reports, adverse event reporting, and label updates require consistent attention.
Companies building a regulatory department from scratch should start with a full-time hire who can establish systems, processes, and a compliance culture. A consultant can help set things up, but someone needs to own it long-term.
If your company plans to make multiple submissions over the next few years, a full-time hire will save money compared to paying consultant rates for each project. Learn more about planning for these hires in our biotech talent acquisition strategy guide.
The Hybrid Approach
Many successful peptide companies use both consultants and full-time staff. This hybrid model gives you the best of both worlds.
A common approach is to hire a full-time regulatory manager to handle ongoing operations and bring in consultants for specialized projects or peak workload periods. This keeps costs manageable while ensuring you always have the right expertise.
| Company Stage | Recommended Approach |
|---|---|
| Pre-clinical, 1 product | Consultant only |
| IND-stage, 1 to 2 products | Consultant plus part-time internal support |
| Clinical-stage, 2 to 3 products | Full-time hire plus consultant for peaks |
| Commercial, 3+ products | Full-time regulatory team plus specialty consultants |
A survey by the Regulatory Affairs Professionals Society found that 45% of biotech companies with fewer than 50 employees rely primarily on consultants for regulatory work, while 82% of companies with more than 200 employees maintain full-time regulatory teams.
How to Evaluate Regulatory Consultants
If you decide to go the consultant route, choosing the right one is critical. Not all consultants deliver the same value.
Look for consultants with direct experience in peptide or closely related therapeutic areas. Ask for specific examples of submissions they have worked on and their outcomes.
Key Questions to Ask Potential Consultants
Ask about their experience with your specific regulatory pathway. A consultant who has guided five peptide INDs through the FDA is far more valuable than one with general pharma experience.
Request references from companies similar to yours in size and stage. Check those references thoroughly and ask about communication style, responsiveness, and whether the consultant met deadlines.
How to Hire a Full-Time Regulatory Professional
If a full-time hire is the right path, take the time to find the right person. Regulatory affairs professionals are in high demand, and the wrong hire can set you back months.
Write a clear job description that specifies the therapeutic areas, regulatory agencies, and submission types you need experience with. Be honest about where your company is in its development journey so candidates can self-select.
For tips on structuring interviews for regulatory hires, check out our article on peptide quality control manager hiring tips, which covers similar evaluation techniques.
Making the Transition
Some companies start with consultants and later transition to full-time hires as they grow. Planning for this transition upfront can save you headaches later.
Ask your consultant to document their processes, contacts, and institutional knowledge as they work. This makes it much easier to hand off to a full-time employee when the time comes.
Match your regulatory staffing model to your pipeline stage: consultants for early, focused needs and full-time hires once submission volume justifies a dedicated role.
Frequently Asked Questions
Can a regulatory consultant handle FDA interactions on my behalf?
Yes, consultants can participate in FDA meetings and calls alongside your team. However, the FDA expects to interact with representatives of the sponsor company, so having at least one internal person involved is important.
How do I know when it is time to switch from a consultant to a full-time hire?
When your annual consultant spending consistently exceeds the cost of a full-time hire, or when regulatory activities require daily attention, it is time to consider a full-time employee. Also look at whether delays are occurring because your consultant is not available when you need them.
What qualifications should a biotech regulatory consultant have?
Look for an advanced degree in a life sciences field, at least 10 years of regulatory affairs experience, and a track record of successful submissions in your therapeutic area. RAC certification from the Regulatory Affairs Professionals Society is a strong credential.
Can I hire a consultant to train my internal team?
Absolutely. Many consultants offer training services alongside their project work. This is a smart way to build internal capabilities while still getting expert help with active submissions.
How do I protect my intellectual property when working with a consultant?
Use a strong confidentiality agreement and clearly define ownership of all work products in your consulting contract. Most experienced consultants are accustomed to these protections and will sign reasonable agreements without pushback.
What is the typical engagement length for a regulatory consultant?
Engagements range from a few weeks for a strategy assessment to over a year for full submission support. The average project-based engagement lasts 3 to 6 months. Retainer arrangements are typically structured on a 6- to 12-month basis with renewal options.
Topics
Jennifer Walsh
Senior Healthcare Staffing Consultant
RN, BSN | 13 years placing clinical professionals in wellness practices
Registered nurse and staffing specialist who has placed over 400 clinical professionals across peptide therapy, hormone optimization, and integrative medicine clinics. Expertise in credentialing and retention strategy.
Reviewed by Jennifer Walsh, RN, April 2026